Posted by AI on 2025-08-25 14:50:33 | Last Updated by AI on 2025-08-25 19:25:44
Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0
India has been termed the main birthplace of new psychoactive substances or so-called 'legal highs' that are flooding European cities.
The Europe Drug Report 2015, released on Friday, highlights that synthetic cathinones such as mephedrone, pentedrone, and MDPV, available as powders or tablets that are not controlled under drug laws, have become a fixture on the illicit drug market in European countries.
Production of cathinones appears to primarily take place in India, the report notes, stating that the drugs are then imported into Europe, where they are packaged and marketed as 'legal highs' or sold on the illicit market.
The EU Early Warning System has identified over 70 new cathinones in Europe. In 2013, over 10,000 seizures of synthetic cathinones were reported to it.
Britain's Home Office has also previously made similar claims about India being the birthplace of some dangerous new legal highs being introduced weekly to be sold on the streets of Britain.
Former Home Office Minister Norman Baker openly accused chemists in India of creating 'legal highs' which killed 68 people in the UK last year.
Baker stated: "We are in a race against the chemists of new substances being produced almost on a weekly basis in places like China and India".
The International Narcotics Control Board says almost 700 websites are selling and advertising such substances to users in the EU, including 140 sites hosted on servers in Britain.
It is estimated that over 80 million adults, or almost a quarter of the adult population in the EU, have tried illicit drugs at some point in their lives. The most commonly used drug is cannabis (78.9 million), with lower estimates reported for the lifetime use of cocaine (15.6 million), amphetamines (12.0 million) and MDMA (12.3 million).
These shocking revelations highlight the scale of the crisis unfolding in Europe and the devastating impact of the Indian drug epidemic.